citric acid; lactic acid; potassium bitartrate · Evofem Inc · NDA 208352
Phexx
Earliest generic entry, as listed
15 Mar 2033
Blocked by patent: US 10568855, US 11337989, US 11439610, US 11992472.
Listed patents · 4 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10568855 | use U-1 | 15 Mar 2033 |
| US 11337989 | use U-1 | 15 Mar 2033 |
| US 11439610 | substance, product | 15 Mar 2033 |
| US 11992472 | use U-1 | 15 Mar 2033 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208352 · 001 · RLD | gel, vaginal | 1%;1.8%;0.4% | 15 Mar 2033 |